Results 101 to 110 of about 1,404,808 (156)

Predictive model based on folate receptor-positive circulating tumor cells in neoadjuvant immunochemotherapy for esophageal cancer. [PDF]

J Gastrointest Oncol
Wang H, Bai H, Yang D, Wang W, Zhou F, Yin M, Yan C, Guo Y, Li K, Zhao J, Yang L, Yu P, Li R.   +12 more
europepmc   +1 more source

Predictive value of folate receptor-positive circulating tumor cells in postoperative progressive disease of non-small cell lung cancer patients. [PDF]

J Cancer Res Clin Oncol
Zhou W, Song M, Song J, You L, Zhu Y, Chen H, Zhou J.   +6 more
europepmc   +1 more source

Study on the expression level of folate receptor γ in thyroid cancer and its association with clinicopathological characteristics. [PDF]

Oncol Lett
Cao J, Li Y, Deng X, Lv B, Han L, Tong L.   +5 more
europepmc   +1 more source

Folate receptor β performs an immune checkpoint function in activated macrophages. [PDF]

Front Immunol
Zhang F, Al-Amin MY, Utturkar S, Jiang R, Cresswell G, Alfar R, Ophaug-Johansen I, Bachman G, Srinivasarao M, Finnell R, Puig-Kröger A, Ratliff T, Low PS.   +12 more
europepmc   +1 more source

Folic acid-functionalized polymer dots encapsulating deep red fluorescent carbon nanodots for specific imaging of folate-receptor-positive cancer cells. [PDF]

RSC Adv
Fan Y, Yang M, Zhuang Y, Chen Y, Li X, Zou W, Huang H.   +6 more
europepmc   +1 more source

Significance and Correlation Analysis of Folate Receptor-Positive Circulating Tumor Cells (FR + CTC) in Colorectal Cancer Patients. [PDF]

Cancer Rep (Hoboken)
Hu R, Lan A, Li D, Liu C.
europepmc   +1 more source

Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab-soravtansine therapy. [PDF]

J Pathol Clin Res
Nasdala A, Kandt LD, Radner M, Schaumann N, Gronewold M, Hillmann P, Christgen H, Hachenberg J, Kuehnle E, Hartmann C, Christgen M.   +10 more
europepmc   +1 more source

Fluorescence Discrimination of Cancer from Inflammation by Selective Targeting Folate Receptor α. [PDF]

Chem Biomed Imaging
Li Y, Guissi NEI, Dong J, Singhal S, Dai B, Butch C, Cai H, Wang Y.   +7 more
europepmc   +1 more source

Evaluation of folate receptor-alpha and other surface markers as potential targets for radionuclide therapy of ovarian cancer. [PDF]

EJNMMI Res
Hunkeler BD, Heimer J, Mapanao AK, Choschzick M, Müller C, Rupp NJ.   +5 more
europepmc   +1 more source

Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial. [PDF]

Nat Commun
Porter RL, Zhou Y, Eskndir N, Hayes M, Polak M, Lee EK, Krasner C, Campos S, Wright AA, Liu JF, Stover EH, Sawyer H, Xiong N, Pfaff KL, Rodig SJ, Tayob N, Zweizig S, John V, Veneris J, Matulonis UA, Konstantinopoulos PA.   +20 more
europepmc   +1 more source